This recorded videoconference on advanced NSCLC for pathologists and laboratory professionals will consist of a 20-minute didactic presentation by a subject matter expert on key actionable driver mutations in patients with advanced NSCLC. In the remaining 40 minutes, two participants will present and share real-world cases and challenges from their institutions and seek feedback from participants and subject matter experts. The session will provide knowledge and best practices related to key actionable driver mutations in patients with advanced NSCLC and guidance on real-life challenges they may face in their institutions.

The videoconferences in this series utilize the Project ECHO^® approach, leveraging technology to provide access to scarce resources, help participants master complex topics through case-based learning, facilitate peer-to-peer sharing of best practices to improve knowledge and outcomes, reduce peer isolation, and foster professional development.

The period to claim credit for attending the live videoconference has now closed. Please register here to participate in the on-demand version of this course

The activity offers 1.0 CME/CMLE credit.

Learning Objectives:

Upon completion of this activity, you should be able to:

• Discuss key actionable driver mutations in patients with advanced NSCLC (eg, EGFR, ALK, ROS1, BRAF)
• Develop and apply effective testing algorithms for patients with advanced NSCLC to ensure appropriate testing for key actionable driver mutations (eg, EGFR, ALK, ROS1, BRAF)
• Emphasize the role of the pathologist in the multidisciplinary lung cancer team.  

Faculty:

Dr. Diana Ionescu, MD, FRCPC, FCAP

Consultant Pathologist at BC Cancer Agency

Clinical Professor, UBC

The University of British Columbia

Department of Pathology and Laboratory Medicine

Vancouver, BC Canada

The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

Credit Designation Statement

The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

ASCP designates this enduring material for a maximum of 1.0 CMLE credit.  This activity meets CMP and state re-licensure requirements for laboratory personnel.

For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time

Method of Participation

To complete the activity and receive credit, the participant must complete the online course. CME certificates will be provided on-line.

Funded by independent educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Pfizer, Inc.